Clindamycin Phosphate Injection — FDA Drug Shortage

Current — Sagent Pharmaceuticals

The FDA lists a drug shortage record for Clindamycin Phosphate Injection (injection) from Sagent Pharmaceuticals with status Current. The shortage was first posted on Mar 21, 2023. Reported reason: Discontinuation of the manufacture of the drug

Shortage details

Status
Current
Company
Sagent Pharmaceuticals
Package NDC
25021-115-06
Dosage Form
Injection
Presentation
Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06)
Initial Posting
Mar 21, 2023

Reason

Discontinuation of the manufacture of the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.